A Study to Evaluate the Safety and Efficacy of CB-03-01 Cream, 1% in Subjects With Facial Acne Vulgaris (25)
Public ClinicalTrials.gov record NCT02608450. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Vehicle-Controlled Study to Evaluate the Safety and Efficacy of Cortexolone 17α-Propionate (CB-03-01) Cream, 1% Applied Twice Daily for 12 Weeks in Subjects With Facial Acne Vulgaris
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The primary objective of this study is to determine the safety and efficacy of CB-03-01 cream, 1%, versus the vehicle cream applied twice daily for 12 weeks in subjects with facial acne vulgaris.
Study identification
- NCT ID
- NCT02608450
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 708 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 9 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 21, 2016 (Actual)
- Primary completion
- Apr 11, 2018 (Actual)
- Completion
- Apr 11, 2018 (Actual)
- Last update posted
- Nov 20, 2020
2016 – 2018
United States locations
- U.S. sites
- 44
- U.S. states
- 18
- U.S. cities
- 37
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Gary M. Petrus, MD PA | Little Rock | Arkansas | 72205 | — |
| Center For Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| Vitiligo & Pigmentation Institute of Southern California | Los Angeles | California | 90036 | — |
| San Diego Sports Medicine and Family Health Center | San Diego | California | 92120 | — |
| Rady Childrens Hospital, Pediatric and Adolescent Dermatology | San Diego | California | 92123 | — |
| Southern California Dermatology | Santa Ana | California | 92701 | — |
| Clinical Science Institute | Santa Monica | California | 90404 | — |
| Memorial Research Medical Clinic dba / Orange County Research Center | Tustin | California | 92780 | — |
| Horizons Clinical Research Center, LLC | Denver | Colorado | 80220 | — |
| Site 0190 | Boca Raton | Florida | 33434 | — |
| Study Protocol, Inc. | Boynton Beach | Florida | 33437 | — |
| Site 0196 | Miami | Florida | 33125 | — |
| Site 0197 | Miami | Florida | 33126 | — |
| Site 0198 | Miami | Florida | 33135 | — |
| Site 0199 | Miami | Florida | 33145 | — |
| Site 0191 | Miami | Florida | 33172 | — |
| Site 0192 | Miami | Florida | 33172 | — |
| Site 0195 | Miami | Florida | 33176 | — |
| Tory Sullivan, M.D., P.A. | North Miami Beach | Florida | 33162 | — |
| Meridien Research | St. Petersburg | Florida | 33709 | — |
| MOORE Clinical Research, Inc. | Tampa | Florida | 33609 | — |
| MedaPhase, Inc. | Newnan | Georgia | 30263 | — |
| Site 0152 | Carmel | Indiana | 46032 | — |
| The Indiana Clinical Trials Center | Plainfield | Indiana | 46168 | — |
| Henry Ford Health System | Detroit | Michigan | 48202 | — |
| MediSearch Clinical Trials | Saint Joseph | Missouri | 64506 | — |
| The Center for Dermatology, Cosmetic & Laser Surgery | Mount Kisco | New York | 10549 | — |
| DermResearch Center of New York, Inc. | Stony Brook | New York | 11790 | — |
| Wake Research Associates | Raleigh | North Carolina | 27612 | — |
| Wake Forest University Health Sciences | Winston-Salem | North Carolina | 27157 | — |
| Oregon Dermatology and Research Center | Portland | Oregon | 97210 | — |
| The Pennsylvania State University and the Milton S. Hershey Medical Center | Hershey | Pennsylvania | 17033 | — |
| Omega Medical Research | Warwick | Rhode Island | 02886 | — |
| Greenville Dermatology, LLC | Greenville | South Carolina | 29607 | — |
| International Clinical Research - Tennessee LLC | Murfreesboro | Tennessee | 37130 | — |
| Tennessee Clinical Research Center | Nashville | Tennessee | 37215 | — |
| Westlake Dermatology Clinical Research Center | Austin | Texas | 78746 | — |
| Bellaire Dermatology Associates | Bellaire | Texas | 77401 | — |
| J&S Studies, Inc. | College Station | Texas | 77845 | — |
| The University of Texas Health Science Center at Houston | Houston | Texas | 77030 | — |
| Austin Institute for Clinical Research, Inc. | Pflugerville | Texas | 78660 | — |
| Clinical Research Associates of Tidewater, Inc. | Norfolk | Virginia | 23507 | — |
| Dermatology Associates | Seattle | Washington | 98101 | — |
| Premier Clinical Research | Spokane | Washington | 99202 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02608450, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 20, 2020 · Synced Oct 19, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT02608450 live on ClinicalTrials.gov.